OFF-TARGET EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: ADDITIONAL THERAPEUTIC BENEFITS
The paper is focused on additional, or off-target, effects of angiotensinconverting enzyme inhibitors (ACEI), zofenopril in particular. This is a new area in the pharmacological research, which is also relevant to antihypertensive agents. The authors present the data on potential interaction between...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2013-12-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/95 |
_version_ | 1827063890218844160 |
---|---|
author | O. Yu. Shaidyuk E. O. Taratukhin |
author_facet | O. Yu. Shaidyuk E. O. Taratukhin |
author_sort | O. Yu. Shaidyuk |
collection | DOAJ |
description | The paper is focused on additional, or off-target, effects of angiotensinconverting enzyme inhibitors (ACEI), zofenopril in particular. This is a new area in the pharmacological research, which is also relevant to antihypertensive agents. The authors present the data on potential interaction between ACEI and acetylsalicylic acid, as well as the results of international multi-centre studies. |
first_indexed | 2024-04-10T03:37:10Z |
format | Article |
id | doaj.art-49677f2fba494e06a228b060b356beaf |
institution | Directory Open Access Journal |
issn | 1728-8800 2619-0125 |
language | Russian |
last_indexed | 2025-03-19T22:38:26Z |
publishDate | 2013-12-01 |
publisher | «SILICEA-POLIGRAF» LLC |
record_format | Article |
series | Кардиоваскулярная терапия и профилактика |
spelling | doaj.art-49677f2fba494e06a228b060b356beaf2024-10-17T12:21:33Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252013-12-01126212310.15829/1728-8800-2013-6-21-2395OFF-TARGET EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: ADDITIONAL THERAPEUTIC BENEFITSO. Yu. Shaidyuk0E. O. Taratukhin1N.I. Pirogov Russian National Medical Research University, MoscowN.I. Pirogov Russian National Medical Research University, MoscowThe paper is focused on additional, or off-target, effects of angiotensinconverting enzyme inhibitors (ACEI), zofenopril in particular. This is a new area in the pharmacological research, which is also relevant to antihypertensive agents. The authors present the data on potential interaction between ACEI and acetylsalicylic acid, as well as the results of international multi-centre studies.https://cardiovascular.elpub.ru/jour/article/view/95prostaglandinsendotheliumbradykinincoronary heart diseaserenal |
spellingShingle | O. Yu. Shaidyuk E. O. Taratukhin OFF-TARGET EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: ADDITIONAL THERAPEUTIC BENEFITS Кардиоваскулярная терапия и профилактика prostaglandins endothelium bradykinin coronary heart disease renal |
title | OFF-TARGET EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: ADDITIONAL THERAPEUTIC BENEFITS |
title_full | OFF-TARGET EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: ADDITIONAL THERAPEUTIC BENEFITS |
title_fullStr | OFF-TARGET EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: ADDITIONAL THERAPEUTIC BENEFITS |
title_full_unstemmed | OFF-TARGET EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: ADDITIONAL THERAPEUTIC BENEFITS |
title_short | OFF-TARGET EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: ADDITIONAL THERAPEUTIC BENEFITS |
title_sort | off target effects of angiotensin converting enzyme inhibitors additional therapeutic benefits |
topic | prostaglandins endothelium bradykinin coronary heart disease renal |
url | https://cardiovascular.elpub.ru/jour/article/view/95 |
work_keys_str_mv | AT oyushaidyuk offtargeteffectsofangiotensinconvertingenzymeinhibitorsadditionaltherapeuticbenefits AT eotaratukhin offtargeteffectsofangiotensinconvertingenzymeinhibitorsadditionaltherapeuticbenefits |